DCGI gave permission to Serum Institute to resume clinical trial of the Oxford Covid-19 vaccine candidate in the country
from Latest News https://ift.tt/3iBZ3uL
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd
Home
Business
Business News
Business Standard
Latest News
Serum Institute gets DCGI nod to resume clinical trial of Oxford vaccine
Wednesday, September 16, 2020
Related Posts:
Minda Industries surges 10%, hits record high on strong Q2 performanceWith the demand uptick in key markets, and expected easing off of the … Read More
Xi, Biden to exchange views on bilateral, int'l issues during virtual meetUS President Joe Biden and Chinese President Xi Jinping will exchange … Read More
18.53 cr unutilised Covid vaccine doses still available with states: GovtMore than 123 crore Covid-19 vaccine doses have so far been provided t… Read More
Heavy rains lash Kerala; 'Orange Alert' sounded for 6 districtsOrange alert denotes very heavy rains from 6 cm to 20 cm in 24 hours … Read More
0 comments: